LAM
REGN icon

Lebenthal Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Lebenthal Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.31M Hold
3,373
– – 0.16% 185
2016
Q4 		$1.24M Buy
3,373
+1,411
+72% +$537K 0.16% 176
2016
Q3 		$789K Sell
1,962
-16
-0.8% -$6.42K 0.1% 221
2016
Q2 		$691K Buy
+1,978
New +$762K 0.09% 226

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Lebenthal Asset Management's REGN Position: Q1 2017 in Review

Lebenthal Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2017 at 3,373 shares worth $1.31M. The position accounts for 0.16% of the portfolio, ranked #185.

Lebenthal Asset Management first reported a position in REGN in Q2 2016 and has held it in 4 quarters since. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Lebenthal Asset Management held 3,373 shares of Regeneron Pharmaceuticals worth $1.31M as of Q1 2017.
  • Lebenthal Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2017.
  • Regeneron Pharmaceuticals made up 0.16% of Lebenthal Asset Management's portfolio in Q1 2017, its #185 holding.
  • Lebenthal Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2016 and has held it in 4 quarters since.
  • 578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.